CTOs on the Move

Hyperfine

www.hyperfine.io

 
Hyperfine`s mission is to make MRI accessible to every patient, regardless of income or resources. Anytime. Anywhere. Hyperfine designed the Swoop™ Portable MR Imaging System to overcome patient transport and dedicated room requirements associated with fixed conventional MRI systems. The Swoop™ system plugs into a standard electrical outlet, uses an Apple iPad® for control, and produces images at a patient`s bedside within minutes, allowing care teams to gain clinical information quickly. Fierce Medtech recently recognized Hyperfine as a 2020 Fierce 15 company for its innovative and creative approach to developing solutions for healthcare providers and patients. Hyperfine is part of ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.hyperfine.io
  • 351A New Whitfield Street
    Guilford, CT USA 06437
  • Phone: 866.796.6767

Executives

Name Title Contact Details

Funding

Hyperfine raised $90M on 02/10/2021

Similar Companies

Pacific Medical

Pacific Medical is a Tracy, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Htv Systems

Htv Systems Ltd is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GlucoTrack

GlucoTrack, Inc (formerly known as Integrity Applications, Inc.) is focused on the design, development, and commercialization of novel technologies for people with diabetes and prediabetes. The Company`s initial product, GlucoTrack®, is a proprietary non-invasive glucose monitoring device designed to obtain glucose level measurements without the pain, incremental cost, difficulty, or discomfort of conventional invasive finger stick devices.

Reprieve Cardiovascular

Reprieve Cardiovascular is led by a seasoned management team with extensive experience in the medical device industry.

Zenflow

Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign prostatic hyperplasia (BPH). Millions of patients do not see effective relief from drugs, yet decline to undergo an invasive surgical procedure with high risk of side effects such as sexual dysfunction.